Latest

Routine genetic testing to guide use of chemotherapy has incorporated a new “African” gene variant which could potentially help save the lives of Black and ethnic minority cancer patients.

A strategic partnership with the NHS North Thames Genomic Medicine Service (NT GMS) designed to ensure better access, understanding and information to genomic medicine and research has been announced by the NHS Race and Health Observatory.

Responding to today’s Government announcement on DNA testing and research, Dr Veline L’Esperance, Senior Clinical Advisor to the Observatory, said:

In a unique pairing, the NHS Race and Health Observatory has announced the signing of a landmark agreement with the National Institute for Health and Care Excellence (NICE) to tackle persistent and systemic ethnic health inequalities.

Generations of Black, Asian and minority ethnic communities could reap the benefits of genomic and precision medicine following the commissioning of a new study.

Black, Asian and ethnic minority communities are poorly represented in genetic medicine research and artificial intelligence-based risk prediction tools used to calculate the chance of developing future disease.

The NHS Genomic Medicine Service was commissioned in October 2018 by NHS England.

Academic general practitioner, Dr Veline L’Esperance, has been appointed as a Clinical Advisor to the Observatory focussing on ethnic and racial inequalities relating to genomics and precision medicine.

The independent NHS Race and Health Observatory has today published a series of invitations to commission reviews which explore the gaps in health care provision for racialised and minority ethnic communities and offer evidence-based recommendations for change.